Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

被引:261
|
作者
Bacioglu, Mehtap [1 ,2 ,3 ]
Maia, Luis F. [1 ,2 ,4 ]
Preische, Oliver [1 ,5 ]
Schelle, Juliane [1 ,2 ,3 ]
Apel, Anja [1 ,6 ]
Kaeser, Stephan A. [1 ,2 ]
Schweighauser, Manuel [1 ,2 ,3 ]
Eninger, Timo [1 ,2 ,3 ]
Lambert, Marius [1 ,2 ]
Pilotto, Andrea [1 ,6 ]
Shimshek, Derya R. [7 ]
Neumann, Ulf [7 ]
Kahle, Philipp J. [1 ,6 ]
Staufenbiel, Matthias [1 ,2 ]
Neumann, Manuela [1 ,8 ]
Maetzler, Walter [1 ,6 ]
Kuhle, Jens [9 ,10 ,11 ]
Jucker, Mathias [1 ,2 ]
机构
[1] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Tuebingen, Germany
[2] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany
[3] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany
[4] Hosp Santo Antonio CHP, Dept Neurol, P-4099001 Oporto, Portugal
[5] Univ Tubingen, Dept Psychiat & Psychotherapy, D-72076 Tubingen, Germany
[6] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, D-72076 Tubingen, Germany
[7] Novartis Pharma AG, Novartis Inst BioMed Res, CH-4002 Basel, Switzerland
[8] Univ Tubingen, Dept Neuropathol, D-72076 Tubingen, Germany
[9] Univ Basel Hosp, Dept Med, Neurol, CH-4031 Basel, Switzerland
[10] Univ Basel Hosp, Dept Biomed, Neurol, CH-4031 Basel, Switzerland
[11] Univ Basel Hosp, Dept Clin Res, Neurol, CH-4031 Basel, Switzerland
基金
新加坡国家研究基金会;
关键词
SUBUNIT PNF-H; TRANSGENIC MICE; CEREBROSPINAL-FLUID; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; PROGNOSTIC BIOMARKER; PARKINSONS-DISEASE; NERVOUS-SYSTEM; AXONOPATHY;
D O I
10.1016/j.neuron.2016.05.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A majority of current disease-modifying therapeutic approaches for age-related neurodegenerative diseases target their characteristic proteopathic lesions (alpha-synuclein, Tau, A beta). To monitor such treatments, fluid biomarkers reflecting the underlying disease process are crucial. We found robust increases of neurofilament light chain (NfL) in CSF and blood in murine models of alpha-synucleinopathies, tauopathy, and beta-amyloidosis. Blood and CSF NfL levels were strongly correlated, and NfL increases coincided with the onset and progression of the corresponding proteopathic lesions in brain. Experimental induction of alpha-synuclein lesions increased CSF and blood NfL levels, while blocking Ab lesions attenuated the NfL increase. Consistently, we also found NfL increases in CSF and blood of human alpha-synucleinopathies, tauopathies, and Alzheimer's disease. Our results suggest that CSF and particularly blood NfL can serve as a reliable and easily accessible biomarker to monitor disease progression and treatment response in mouse models and potentially in human proteopathic neurodegenerative diseases.
引用
收藏
页码:56 / 66
页数:11
相关论文
共 50 条
  • [1] Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (vol 91, pg 56, 2016)
    Bacioglu, Mehtap
    Maia, Luis F.
    Preische, Oliver
    Schelle, Juliane
    Apel, Anja
    Kaeser, Stephan A.
    Schweighauser, Manuel
    Eninger, Timo
    Lambert, Marius
    Pilotto, Andrea
    Shimshek, Derya R.
    Neumann, Ulf
    Kahle, Philipp J.
    Staufenbiel, Matthias
    Neumann, Manuela
    Maetzler, Walter
    Kuhle, Jens
    Jucker, Mathias
    NEURON, 2016, 91 (02) : 494 - 496
  • [2] Neurofilament light chain (NfL) as a possible biomarker for drug efficacy in mouse models of neurodegenerative diseases
    Hirouchi, Masakazu
    Aoyagi, Atsushi
    Bond, Annalise
    Giles, Kurt
    Condello, Carlo
    Prusiner, Stanley B.
    PRION, 2019, 13 : 116 - 116
  • [3] Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
    Gaiottino, Johanna
    Norgren, Niklas
    Dobson, Ruth
    Topping, Joanne
    Nissim, Ahuva
    Malaspina, Andrea
    Bestwick, Jonathan P.
    Monsch, Andreas U.
    Regeniter, Axel
    Lindberg, Raija L.
    Kappos, Ludwig
    Leppert, David
    Petzold, Axel
    Giovannoni, Gavin
    Kuhle, Jens
    PLOS ONE, 2013, 8 (09):
  • [4] CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
    Skillback, Tobias
    Farahmand, Bahman
    Bartlett, Jonathan W.
    Rosen, Christoffer
    Mattsson, Niklas
    Nagga, Katarina
    Kilander, Lena
    Religa, Dorota
    Wimo, Anders
    Winblad, Bengt
    Rosengren, Lars
    Schott, Jonathan M.
    Blennow, Kaj
    Eriksdotter, Maria
    Zetterberg, Henrik
    NEUROLOGY, 2014, 83 (21) : 1945 - 1953
  • [5] CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP
    Rojas, Julio C.
    Bang, Jee
    Lobach, Iryna V.
    Tsai, Richard M.
    Rabinovici, Gil D.
    Miller, Bruce L.
    Boxer, Adam L.
    NEUROLOGY, 2018, 90 (04) : E273 - +
  • [6] Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study
    Gotze, Karl
    Vrillon, Agathe
    Dumurgier, Julien
    Indart, Sandrine
    Sanchez-Ortiz, Marta
    Slimi, Hela
    Raynaud-Simon, Agathe
    Cognat, Emmanuel
    Martinet, Matthieu
    Zetterberg, Henrik
    Blennow, Kaj
    Hourregue, Claire
    Bouaziz-Amar, Elodie
    Paquet, Claire
    Lilamand, Matthieu
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [7] CSF neurofilament light chain profiling and quantitation in neurological diseases
    Leckey, Claire A.
    Coulton, John B.
    Giovannucci, Tatiana A.
    He, Yingxin
    Aslanyan, Aram
    Laban, Rhiannon
    Heslegrave, Amanda
    Doykov, Ivan
    Ammoscato, Francesca
    Chataway, Jeremy
    De Angelis, Floriana
    Gnanapavan, Sharmilee
    Byrne, Lauren M.
    Schott, Jonathan M.
    Wild, Edward J.
    Barthelemy, Nicolas R.
    Zetterberg, Henrik
    Wray, Selina
    Bateman, Randall J.
    Mills, Kevin
    Paterson, Ross W.
    BRAIN COMMUNICATIONS, 2024, 6 (03)
  • [8] Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases
    Giovanni Palermo
    Sonia Mazzucchi
    Alessandra Della Vecchia
    Gabriele Siciliano
    Ubaldo Bonuccelli
    Carole Azuar
    Roberto Ceravolo
    Simone Lista
    Harald Hampel
    Filippo Baldacci
    Molecular Neurobiology, 2020, 57 : 4667 - 4691
  • [9] Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases
    Palermo, Giovanni
    Mazzucchi, Sonia
    Della Vecchia, Alessandra
    Siciliano, Gabriele
    Bonuccelli, Ubaldo
    Azuar, Carole
    Ceravolo, Roberto
    Lista, Simone
    Hampel, Harald
    Baldacci, Filippo
    MOLECULAR NEUROBIOLOGY, 2020, 57 (11) : 4667 - 4691
  • [10] Neurofilament light chain and disease progression in MS
    Bhan, A.
    Jacobsen, C.
    Myhr, K. -M.
    Nyland, H.
    Lode, K.
    Farbu, E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 272 - 272